I take creatine myself. But personal experience is not science. Here is what the data actually says, and why we are still deciding.
Creatine supplementation and cognitive function is one of the most discussed and most misrepresented topics in brain health right now. Here is what the evidence actually shows and why it is not enough.
Everyone talks about creatine for the brain right now. Podcasts. Headlines. Influencers who have just discovered what athletes have known for thirty years.
Most of what is being said is either incomplete or misleading. Not wrong about muscle. Wrong about what that muscle evidence actually tells us about the brain.
I take creatine personally. On hard days, demanding weeks, when sleep is short and the pressure is high, I sometimes go up to 15 grams. And honestly? I feel a real difference. Sharper. More recovered mentally. The effect feels significant.
But here is what I keep reminding myself. I do a lot of things for my brain. Sleep, cold exposure, training, diet, a full supplement stack. When everything is layered together, it is genuinely hard to isolate what is doing what. I keep taking creatine because subjectively it seems to help. But I cannot honestly tell you it is the creatine.
And that honest uncertainty is exactly why creatine is not in Axolt.
We Do Not Move on One Study. Or One Podcast.
At Axolt, our team including science leads, research advisors, and medical consultants, go through the full body of evidence together before anything goes into the formula. We look at effect size, sample quality, replication, mechanism, and regulatory standing. We ask whether we understand a compound well enough to stand behind it at scale, for real people.
One study does not set our standard. A podcast does not set our standard. Rigorous, replicated, peer-reviewed evidence sets our standard. That is what we did with creatine. This is what we found.
The Muscle Evidence Is Rock Solid. We Respect That.
Let us start with what is not in dispute.
In 1992, Harris et al. showed that a loading protocol of roughly 20 g per day for five to six days increased muscle creatine by 20 to 40 percent. By 1996, Hultman et al. confirmed that 3 g per day maintenance sustained those elevated stores after loading. This has been replicated across dozens of trials over three decades. Direct biopsy. Large effects. Consistent results.
For skeletal muscle, creatine is as well supported as any supplement gets. The loading protocol, maintenance dose, and tissue saturation are all precisely characterized. If you train and want more from your muscles, creatine is one of the clearest decisions in sports nutrition. No debate from us on that.
The Brain Is a Different Organ Entirely.
Here is where the media narrative starts to drift from what the data actually shows.
In 1999, Dechent et al. used magnetic resonance spectroscopy to measure brain creatine directly after 20 g per day for four weeks. Brain creatine went up by roughly 8 to 10 percent depending on region. That sounds meaningful until you compare it to what the exact same dose does to muscle: 20 to 50 percent. Same dose. Completely different tissue.
The clearest evidence came from Solis et al. in 2017. They measured both muscle and brain in the same people after standard loading. Muscle phosphocreatine increased robustly. Brain creatine? Only about 3.7 to 4 percent. The brain was receiving the identical dose as the body. It barely responded.
Why? The brain makes its own creatine.
The brain has an internal synthesis pathway and tightly regulates what it absorbs from the bloodstream. Standard dietary variation does not move brain creatine levels. Vegetarians consume roughly 45 times less dietary creatine than omnivores. Brain creatine on imaging? Normal in both groups.
The brain is not passively absorbing what you give it. It is actively defending its own set point.
What the Cognitive Research Actually Shows.
There is real signal here. We are not dismissing it.
Across controlled imaging studies, roughly 10 of 13 trials detect statistically significant increases in brain creatine following supplementation. But effects are small, slow, and variable compared to muscle. The cognitive data mirrors this.
Among 18 studies in healthy individuals, 14 report improvements in at least one cognitive domain. A 2024 meta-analysis by Xu et al. covering 16 randomized controlled trials found significant effects on memory (SMD 0.31) and processing speed. The most complete mechanistic result to date is Gordji-Nejad et al. (2024), which used brain imaging alongside cognitive testing during sleep deprivation and found both improved.
But the pattern is consistent. The strongest effects show up in stressed, sleep-deprived, older, or clinically compromised individuals. In healthy, well-rested adults, results are materially weaker. In ME/CFS and Alzheimer's populations, both brain creatine and cognition moved together. In healthy rested subjects, neither did.
The difference may not be the dose. It may be the demand.
What the Regulators Say.
This is the part most content creators skip entirely.
EFSA 2024
In November 2024, the European Food Safety Authority evaluated a formal application to approve a health claim linking creatine supplementation to improved cognitive function. EFSA reviewed 21 human intervention studies and concluded that a cause-and-effect relationship between creatine supplementation and improved cognitive performance could not be established based on the available data.
Only one of ten studies in healthy subjects showed an effect, at 20 g per day for seven days. The EU has therefore not authorized any health claims for creatine and cognition.
EFSA does approve the health claim for creatine and physical performance. Muscle, yes. Brain, not confirmed.
US FDA
The US Food and Drug Administration classifies creatine monohydrate as Generally Recognized as Safe (GRAS) at standard doses for healthy adults, a classification confirmed in 2020. The FDA has not approved any specific health claims for creatine and cognitive function.
The Questions We Cannot Yet Answer.
Our team went through this evidence honestly. Here is where we land on the open questions:
• What dose actually moves brain creatine meaningfully? Standard doses around 5 g per day show only roughly 4 percent change. Higher doses of 20 g per day show 9 to 11 percent but sample sizes are small and placebo controls are often missing.
• Who does it actually help? Evidence is strongest for stressed, sleep-deprived, older, or clinically compromised individuals. For healthy, well-rested adults, the case is weaker.
• Does brain creatine even drive the cognitive effects? Most cognitive studies never measured brain creatine directly. The mechanism still needs direct confirmation.
• Is creatine monohydrate the right form for brain delivery? It is the gold standard for muscle. Whether it is optimal for crossing the blood-brain barrier at meaningful levels is a separate, open question.
Until we can answer these with confidence, we will not add it. Every ingredient in Axolt went through this same process. Sorry it takes time. That is the point.
What This Tells Us About How to Actually Support the Brain
Here is the deeper insight the creatine data keeps pointing toward.
The brain is not a passive receiver. It actively regulates what it lets in, what it synthesizes internally, and how it allocates energy across its systems. You cannot simply flood it with a compound and expect the same response you get from muscle tissue. The brain has its own logic.
This is precisely the insight behind the Axolt Brain Health Pyramid. Rather than trying to override the brain’s regulatory systems from the outside, Axolt’s approach is to work with them and to support the internal systems the brain already uses to sustain itself: its neurotransmitter synthesis pathways, its waste clearance, its inflammatory balance, its blood supply, its cellular energy production.
The pyramid has nine layers, each addressing a system the brain depends on:
• Healthy Gut — roughly 70% of neurotransmitter precursors are produced in the gut, not the brain. The brain’s own neurochemistry depends on what happens downstream.
• Optimal Blood Flow — the brain cannot store oxygen or glucose. Every system inside it depends on a steady, well-maintained supply.
• Healthy Inflammatory Response — low-grade neuroinflammation is one of the primary drivers of cognitive decline, and one of the systems most responsive to targeted nutritional support.
• Effective Glymphatic System — the brain’s dedicated overnight waste clearance network. Without it, the metabolic byproducts of daily cognitive work accumulate and compound.
• Resilient Blood-Brain Barrier — controls what enters the brain. Its integrity is critical for protection and for efficient delivery of the nutrients the brain actually accepts.
• Strong Glial Cells, Efficient Neurons, Plentiful Mitochondria, and Balanced Neurochemicals — the inner layers where cognitive performance is ultimately expressed, and where Axolt’s formula does its work.
This is not the approach of a stimulant or a single-compound hack. It is a systems-level nutritional foundation designed to support everything the brain uses to take care of itself. You can read how every layer works, and which ingredients support each one, at axoltbrain.com/pages/how-it-works.
Creatine may yet find its place in this framework. But only once we understand how it actually interacts with the brain’s regulatory systems — not just muscle tissue.
Where We Stand Right Now.
Creatine for cognitive function is a plausible and active area of research. The question is not whether it works for muscle. It does, definitively. The question is whether we understand how, when, and for whom it works in the brain.
We are actively evaluating it. A next version of Axolt is in development and creatine is genuinely on the table. But we will not add anything until we are confident in the form, the dose, and who it actually helps. Safety and efficacy first. Always.
You can follow how our formulation thinking evolves at axoltbrain.com. We post our reasoning openly. Every ingredient. Every decision.
FAQs
Does creatine improve brain function?
The evidence is promising but context-dependent. A 2024 meta-analysis of 16 randomised controlled trials found significant effects on memory and processing speed. However, effects are strongest in stressed, sleep-deprived, older, or clinically compromised individuals. In healthy, well-rested adults, results are weaker and less consistent.
Why does creatine work better for muscle than brain?
Because the brain makes its own creatine and tightly regulates absorption from the bloodstream. Standard loading increases muscle creatine by 20 to 50 percent. The same protocol increases brain creatine by only roughly 4 percent. The brain defends its own set point regardless of what you ingest.
Has EFSA approved creatine for brain health?
No. In November 2024, EFSA evaluated 21 human intervention studies and concluded that a cause-and-effect relationship between creatine supplementation and improved cognitive performance could not be established. EFSA does approve the health claim for creatine and physical performance in exercise.
Is creatine FDA approved?
The FDA classifies creatine monohydrate as Generally Recognised as Safe (GRAS) for healthy adults at standard doses, confirmed in 2020. The FDA has not approved any cognitive health claims for creatine.
Why is creatine not in Axolt?
We are still working through the open questions: optimal dose for brain delivery, which populations actually benefit, whether brain creatine is even the mechanism behind cognitive effects, and whether monohydrate is the right form. When we can answer these confidently, we will consider adding it. Not before.
If creatine is not in Axolt, what does Axolt do for brain health?
Axolt works with the brain’s own regulatory systems rather than trying to override them. The Axolt Brain Health Pyramid addresses nine interconnected biological systems: gut-brain axis, cerebral blood flow, inflammatory response, glymphatic clearance, blood-brain barrier integrity, glial cells, neurons, mitochondria, and neurochemical balance. Each layer supports the internal infrastructure the brain uses to sustain cognitive function. Rather than flooding the brain with a single compound it actively resists, Axolt builds the foundation underneath.
Will Axolt add creatine in the future?
Possibly. It is actively under evaluation for the next version of the formula. We post updates at axoltbrain.com.
Peer Review Notes
All claims are supported by peer-reviewed sources. Limitations are flagged for transparency.
Harris et al. (1992), Clin Sci
Foundational muscle loading data. N=17. Direct biopsy. Replicated across 30 years. CONFIDENCE: HIGH.
Hultman et al. (1996), J Appl Physiol
Established maintenance dose post-loading. N=31. Direct biopsy. CONFIDENCE: HIGH.
Dechent et al. (1999), Am J Physiol
First MRS measurement of brain creatine. N=6. No placebo. Very small sample. Directional only. CONFIDENCE: LOW TO MEDIUM.
Solis et al. (2017), J Appl Physiol
Dual-tissue comparison in same subjects. N=16. Confirms approximately 4 percent brain vs 20 to 50 percent muscle response. No placebo. CONFIDENCE: MEDIUM.
Solis et al. (2014), Br J Nutr
Vegetarian vs omnivore brain creatine via MRS. N=40. Demonstrates the brain’s internal creatine regulation. CONFIDENCE: MEDIUM.
Rae et al. (2003), Proc R Soc B
Cognitive improvement in vegetarians. N=45. p less than 0.0001 for working memory. Brain creatine not measured. Mechanism gap. CONFIDENCE: MEDIUM.
Gordji-Nejad et al. (2024), Sci Rep
High-dose MRS plus cognitive outcomes during sleep deprivation. N=15. No placebo. Most mechanistically complete study to date. CONFIDENCE: MEDIUM.
Xu et al. (2024), Front Nutr
Meta-analysis of 16 RCTs. Memory SMD 0.31, processing speed confirmed. Stronger in stressed and clinical populations. Most studies did not measure brain creatine directly. CONFIDENCE: MEDIUM TO HIGH.
EFSA Panel on Nutrition (2024), EFSA Journal 22(11) e9100
Formal EU regulatory review of 21 human intervention studies. No cause-and-effect relationship established for creatine and cognitive function. Only 1 of 10 healthy-subject studies showed an effect. CONFIDENCE: REGULATORY STANDARD.
US FDA GRAS Notice (2020)
Creatine monohydrate classified as Generally Recognised as Safe at standard doses. No cognitive health claims approved. CONFIDENCE: REGULATORY STANDARD.
Godlewska et al. (2024), Smith (2025), Candow (2026)
Emerging evidence in Alzheimer’s and ageing populations. Active research area. CONFIDENCE: PRELIMINARY.
These statements have not been evaluated by the Food and Drug Administration (FDA) or the European Food Safety Authority (EFSA). This product is not intended to diagnose, treat, cure, or prevent any disease. Results may vary based on individual use. Consult your healthcare provider before starting any new supplement.
